Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 23 (5), 1181-1188

Revealing the Complex Genetic Architecture of Obsessive-Compulsive Disorder Using Meta-Analysis


Revealing the Complex Genetic Architecture of Obsessive-Compulsive Disorder Using Meta-Analysis

International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS). Mol Psychiatry.


Two obsessive-compulsive disorder (OCD) genome-wide association studies (GWASs) have been published by independent OCD consortia, the International Obsessive-Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and the OCD Collaborative Genetics Association Study (OCGAS), but many of the top-ranked signals were supported in only one study. We therefore conducted a meta-analysis from the two consortia, investigating a total of 2688 individuals of European ancestry with OCD and 7037 genomically matched controls. No single-nucleotide polymorphisms (SNPs) reached genome-wide significance. However, in comparison with the two individual GWASs, the distribution of P-values shifted toward significance. The top haplotypic blocks were tagged with rs4733767 (P=7.1 × 10-7; odds ratio (OR)=1.21; confidence interval (CI): 1.12-1.31, CASC8/CASC11), rs1030757 (P=1.1 × 10-6; OR=1.18; CI: 1.10-1.26, GRID2) and rs12504244 (P=1.6 × 10-6; OR=1.18; CI: 1.11-1.27, KIT). Variants located in or near the genes ASB13, RSPO4, DLGAP1, PTPRD, GRIK2, FAIM2 and CDH20, identified in linkage peaks and the original GWASs, were among the top signals. Polygenic risk scores for each individual study predicted case-control status in the other by explaining 0.9% (P=0.003) and 0.3% (P=0.0009) of the phenotypic variance in OCGAS and the European IOCDF-GC target samples, respectively. The common SNP heritability in the combined OCGAS and IOCDF-GC sample was estimated to be 0.28 (s.e.=0.04). Strikingly, ∼65% of the SNP-based heritability in the OCGAS sample was accounted for by SNPs with minor allele frequencies of ⩾40%. This joint analysis constituting the largest single OCD genome-wide study to date represents a major integrative step in elucidating the genetic causes of OCD.

Conflict of interest statement

Conflict of Interest: None of the authors report a conflict related to this article.


Figure 1.
Figure 1.
Manhattan plot of genotyped and imputed single-nucleotide polymorphisms (SNPs) for 2,688 OCD cases and 7,031 controls from the IOCDF-GC, OCGAS, and GPC consortia. Red line indicates the genome-wide significance threshold of p=5×10−8.
Figure 2.
Figure 2.. Polygenic Risk Score Analysis in OCD.
The variance explained in two target samples (OCTR, consisting of 630cases and 630 pseudo-controls; IOEU, consisting of 1032 cases and 4100 controls) is based on risk scores derived from an aggregated sum of weighted single-nucleotide polymorphism risk allele effect sizes estimated from the discovery samples (IOCDF-GC without IOAJ, consisting of 1623 cases and 5113 controls; OCGAS, consisting of 974 cases and 663 controls) at eight significance thresholds. The numbers of SNPs used at each significance thresholds for PRS were listed on the top of the corresponding bars. The y-axis indicates Nagelkerke’s pseudo R2.

Similar articles

  • Genome-wide association study of obsessive-compulsive disorder.
    Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Davis LK, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, Illman C, Mayerfeld C, Konkashbaev A, Liu C, Pluzhnikov A, Tikhomirov A, Edlund CK, Rauch SL, Moessner R, Falkai P, Maier W, Ruhrmann S, Grabe HJ, Lennertz L, Wagner M, Bellodi L, Cavallini MC, Richter MA, Cook EH Jr, Kennedy JL, Rosenberg D, Stein DJ, Hemmings SM, Lochner C, Azzam A, Chavira DA, Fournier E, Garrido H, Sheppard B, Umaña P, Murphy DL, Wendland JR, Veenstra-VanderWeele J, Denys D, Blom R, Deforce D, Van Nieuwerburgh F, Westenberg HG, Walitza S, Egberts K, Renner T, Miguel EC, Cappi C, Hounie AG, Conceição do Rosário M, Sampaio AS, Vallada H, Nicolini H, Lanzagorta N, Camarena B, Delorme R, Leboyer M, Pato CN, Pato MT, Voyiaziakis E, Heutink P, Cath DC, Posthuma D, Smit JH, Samuels J, Bienvenu OJ, Cullen B, Fyer AJ, Grados MA, Greenberg BD, McCracken JT, Riddle MA, Wang Y, Coric V, Leckman JF, Bloch M, Pittenger C, Eapen V, Black DW, Ophoff RA, Strengman E, Cusi D, Turiel M, Frau F, Macciardi F, Gibbs JR, Cookson MR, Singleton A; North American Brain Expression Consortium, Hardy J; UK Brain Expression Database, Crenshaw AT, Parkin MA, Mirel DB, Conti DV, Purcell S, Nestadt G, Hanna GL, Jenike MA, Knowles JA, Cox N, Pauls DL. Stewart SE, et al. Mol Psychiatry. 2013 Jul;18(7):788-98. doi: 10.1038/mp.2012.85. Epub 2012 Aug 14. Mol Psychiatry. 2013. PMID: 22889921 Free PMC article.
  • Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.
    Mattheisen M, Samuels JF, Wang Y, Greenberg BD, Fyer AJ, McCracken JT, Geller DA, Murphy DL, Knowles JA, Grados MA, Riddle MA, Rasmussen SA, McLaughlin NC, Nurmi EL, Askland KD, Qin HD, Cullen BA, Piacentini J, Pauls DL, Bienvenu OJ, Stewart SE, Liang KY, Goes FS, Maher B, Pulver AE, Shugart YY, Valle D, Lange C, Nestadt G. Mattheisen M, et al. Mol Psychiatry. 2015 Mar;20(3):337-44. doi: 10.1038/mp.2014.43. Epub 2014 May 13. Mol Psychiatry. 2015. PMID: 24821223 Free PMC article.
  • Obsessive-compulsive symptoms in a large population-based twin-family sample are predicted by clinically based polygenic scores and by genome-wide SNPs.
    den Braber A, Zilhão NR, Fedko IO, Hottenga JJ, Pool R, Smit DJ, Cath DC, Boomsma DI. den Braber A, et al. Transl Psychiatry. 2016 Feb 9;6(2):e731. doi: 10.1038/tp.2015.223. Transl Psychiatry. 2016. PMID: 26859814 Free PMC article.
  • The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: Overview.
    Mattina GF, Steiner M. Mattina GF, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jun 3;67:107-16. doi: 10.1016/j.pnpbp.2016.01.012. Epub 2016 Jan 28. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26827635 Review.
  • Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.
    Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Bloch MH, et al. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):850-8. doi: 10.1002/ajmg.b.30699. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18186076 Review.
See all similar articles

Cited by 29 articles

See all "Cited by" articles

Publication types

MeSH terms